603014 logo

Shandong Weigao Blood Purification Products Co., Ltd. Stock Price

SHSE:603014 Community·CN¥16.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

603014 Share Price Performance

CN¥0
-41.41 (-100.00%)
CN¥0
-41.41 (-100.00%)
Price CN¥0

603014 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with proven track record.

0 Risks
3 Rewards

Shandong Weigao Blood Purification Products Co., Ltd. Key Details

CN¥3.7b

Revenue

CN¥2.2b

Cost of Revenue

CN¥1.5b

Gross Profit

CN¥1.0b

Other Expenses

CN¥474.4m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Mar 28, 2026
1.14
40.79%
12.84%
0%
View Full Analysis

About 603014

Founded
2004
Employees
n/a
CEO
Cunming Zhang
WebsiteView website
www.wego-healthcare.com

Shandong Weigao Blood Purification Products Co., Ltd. engages in the research and development, production, and sale of blood purification medical products in China. It offers dialyzers, dialysis machines, hemodialysis machines, A.V. fistula needle sets, extracorporeal blood circuits, bloodlines, and plasma separators; peritoneal dialysis (PD) solutions; and PD consumables, such as bag free set, catheter joints, and transfer tube sets. The company was founded in 2004 and is based in Weihai, China.

Recent 603014 News & Updates

Recent updates

No updates